Benzathine Penicillin Dosing for Syphilis
For early syphilis (primary, secondary, or early latent), administer benzathine penicillin G 2.4 million units intramuscularly as a single dose; for late latent syphilis or syphilis of unknown duration, administer 7.2 million units total as three weekly doses of 2.4 million units each. 1, 2
Adult Dosing by Stage
Early Syphilis (Primary, Secondary, Early Latent)
- Single dose of 2.4 million units IM is the standard treatment 2, 1
- Recent high-quality evidence confirms that one dose is noninferior to three doses, with 76% serologic response at 6 months in both regimens 3
- This single-dose regimen achieves 90-100% treatment success rates 4
- Administration should be deep intramuscular in the upper outer quadrant of the buttock (dorsogluteal) or ventrogluteal site 1
Late Latent Syphilis or Unknown Duration
- Total of 7.2 million units administered as three separate doses of 2.4 million units IM at weekly intervals 2, 1
- Each injection must be spaced exactly 7 days apart 2
- If a dose is missed, pharmacologic considerations suggest a 10-14 day interval may be acceptable before restarting the sequence, though this is not well-established 2
Neurosyphilis
- Requires intravenous therapy, not intramuscular benzathine penicillin 5
- Aqueous crystalline penicillin G 18-24 million units daily (3-4 million units IV every 4 hours) for 10-14 days 5
Pediatric Dosing
Children with Acquired Syphilis (≥1 month old)
- 50,000 units/kg IM, up to the adult dose of 2.4 million units for early syphilis as a single dose 2
- For late latent syphilis: 50,000 units/kg IM administered as three doses at weekly intervals (total 150,000 units/kg up to 7.2 million units) 2
- All children require CSF examination to exclude neurosyphilis before treatment 2
Congenital Syphilis
- Infants under 2 years: 50,000 units/kg body weight 1
- Ages 2-12 years: adjust based on adult dosage schedule 1
- Treatment regimens vary significantly based on maternal treatment history and infant evaluation findings 2
Special Populations
HIV-Infected Patients
- Use the same single-dose regimen (2.4 million units IM) for early syphilis 2
- A 2025 randomized trial demonstrated that single-dose therapy was noninferior to three-dose therapy in HIV-infected individuals, with 76% serologic response in the single-dose group versus 71% in the three-dose group 3
- Earlier 2017 data showed 93% success with single dose versus 100% with three doses in per-protocol analysis, supporting single-dose treatment 6
- Additional doses do not enhance efficacy regardless of HIV status 2
- More frequent serologic follow-up (every 3 months) is recommended 7
Pregnant Women
- Same stage-appropriate penicillin dosing as non-pregnant adults 8, 5
- For primary, secondary, or early latent: 2.4 million units IM single dose 8
- Some specialists recommend a second dose of 2.4 million units IM one week later, especially in third trimester or with secondary syphilis 8
- For late latent or unknown duration: 7.2 million units total as three weekly doses of 2.4 million units 8
- Penicillin is the only proven effective treatment to prevent mother-to-fetal transmission 8
- Women with penicillin allergy must undergo desensitization and then receive penicillin—no alternatives are acceptable 8
- If any dose is missed, the entire course must be repeated 2
Follow-Up and Treatment Response
Serologic Monitoring
- For early syphilis: clinical and serologic evaluation at 6 and 12 months 2
- For latent syphilis: repeat quantitative nontreponemal tests at 6,12, and 24 months 2
- A fourfold decline in titer (two dilutions) is expected within 6 months for primary/secondary syphilis 5
- Serologic response is generally slower (12-24 months) for latent syphilis 4
Treatment Failure Criteria
- Titers increase fourfold after initial decline 2
- Initially high titer (>1:32) fails to decline at least fourfold within 12-24 months 2
- Signs or symptoms attributable to syphilis develop 2
- For treatment failure: administer benzathine penicillin G 2.4 million units IM weekly for 3 weeks, unless CSF examination indicates neurosyphilis 2
Critical Pitfalls to Avoid
- Never use tetracyclines, doxycycline, or erythromycin in pregnant women—these do not prevent congenital syphilis 8
- Do not inject benzathine penicillin intravenously, into or near an artery or nerve, or admix with other IV solutions 1
- Avoid administration in the anterolateral thigh due to adverse effects; use dorsogluteal or ventrogluteal sites instead 1
- Do not assume that persistent low-titer reactivity (serofast state) necessarily indicates treatment failure—a significant proportion of patients remain seropositive despite adequate treatment 7, 4
- Never compare titers between different test types (VDRL vs RPR) as they are not directly comparable 7
- Inject at a slow, steady rate to prevent needle blockage due to high concentration of suspended material 1